Literature DB >> 1939110

A factor that activates oscillatory chloride currents in Xenopus oocytes copurifies with a subfraction of serum albumin.

G Tigyi1, A Henschen, R Miledi.   

Abstract

Vertebrate blood sera contain a factor that elicits oscillatory chloride currents in Xenopus oocytes through activation of the phosphatidylinositol second messenger system. This factor was purified from rabbit and human sera by a sequence of Blue-Agarose chromatography, concanavalin A affinity chromatography, and hydroxyapatite fractionation, yielding a single active protein band (67 kDa). This protein is a subfraction of serum albumin, as revealed by its molecular mass, isoelectric properties, peptide maps, amino acid composition, and NH2-terminal sequence. Moreover, the factor could be purified with a monoclonal antibody to serum albumin and its ability to elicit oscillatory currents was inhibited by several polyclonal-monospecific antibodies to serum albumin. Various commercial high purity albumin preparations elicited oscillatory currents in oocytes. The activity of albumin was partially reduced by charcoal absorption and was greatly diminished when crystalline albumin was extracted with dry methanol. However, the activity was resistant to extraction with chloroform/ether, disulfide cleavage, and denaturation with 8 M urea, 6 M guanidinium chloride, and 1% sodium dodecyl sulfate. Trypsin or lipase treatment substantially reduced the potency of the active albumin, but neither treatment alone abolished the factor even after prolonged digestion. In contrast to serum or serum albumin, freshly collected blood plasma or purified plasma albumin did not evoke oscillatory currents. This indicates that some of the plasma albumin changes during blood coagulation and acquires a "factor" that makes it capable of activating the phosphatidylinositol-Ca2+ system in Xenopus oocytes. The serum factor also activates the phosphatidylinositol system in a variety of mammalian cells, suggesting that the modified albumin may play a role in cellular events related to tissue repair following injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939110

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Inhibition of choline acetyltransferase activity by serum albumin modified with octanoic acid and other fatty acids.

Authors:  Y Ninomiya; Y Kayama
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

2.  Activation of muscarinic K+ current in guinea-pig atrial myocytes by sphingosine-1-phosphate.

Authors:  M Bünemann; B Brandts; D M zu Heringdorf; C J van Koppen; K H Jakobs; L Pott
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

3.  Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.

Authors:  K Liliom; G Sun; M Bünemann; T Virág; N Nusser; D L Baker; D A Wang; M J Fabian; B Brandts; K Bender; A Eickel; K U Malik; D D Miller; D M Desiderio; G Tigyi; L Pott
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

Review 4.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

5.  Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes.

Authors:  A Nadal; E Fuentes; J Pastor; P A McNaughton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Membrane-delimited activation of muscarinic K current by an albumin-associated factor in guinea-pig atrial myocytes.

Authors:  M Bünemann; L Pott
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

7.  A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.

Authors:  Jonathan K Fleming; Thomas R Glass; Steve J Lackie; Jonathan M Wojciak
Journal:  J Lipid Res       Date:  2016-07-21       Impact factor: 5.922

8.  Serum contains a potent factor that decreases beta-adrenergic receptor-stimulated L-type Ca2+ current in cardiac myocytes.

Authors:  K Banach; M Bünemann; J Hüser; L Pott
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

9.  Activation of muscarinic K+ current in guinea-pig atrial myocytes by a serum factor.

Authors:  K Banach; J Hüser; P Lipp; M C Wellner; L Pott
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

10.  Actions of serum and plasma albumin on intracellular Ca2+ in human endothelial cells.

Authors:  E Fuentes; A Nadal; R Jacob; P McNaughton
Journal:  J Physiol       Date:  1997-10-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.